THE PAPANICOLAOU SMEAR AS A SENTINEL SCREENING-TEST FOR HEALTH SCREENING IN WOMEN

Citation
Wj. Hueston et Ma. Stiles, THE PAPANICOLAOU SMEAR AS A SENTINEL SCREENING-TEST FOR HEALTH SCREENING IN WOMEN, Archives of internal medicine, 154(13), 1994, pp. 1473-1477
Citations number
26
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00039926
Volume
154
Issue
13
Year of publication
1994
Pages
1473 - 1477
Database
ISI
SICI code
0003-9926(1994)154:13<1473:TPSAAS>2.0.ZU;2-G
Abstract
Background: There has been evidence that, in primary care practices, h ealth screening tests are not ordered in random fashion but instead ar e coupled or bundled into distinct groups. This study was performed to determine if the Papanicolaou (Pap) smear serves as a marker for othe r health screening tests. Methods: The study consisted of a retrospect ive chart review of female patients over the age of 18 years at three rural health clinics, followed by a prospective study of patients duri ng a 3-month period in five rural family practice clinics. The study f ocused on whether a Pap smear was performed and whether a breast exami nation, mammogram, rectal examination or stool occult blood test, or s erum cholesterol testing was performed. Results: In both the retrospec tive and prospective series, patients who received Pap smears were sig nificantly more likely to receive breast examinations, mammograms, col orectal screening, and cholesterol tests. In addition, the coupling of other screening tests with the Pap smear appeared to increase with ad vancing patient age, with a decline after age 70 years. In patients wh o did not have Pap smears, only cholesterol testing increased as patie nts aged. Conclusion: Health screening tests in women are associated w ith the performance of a Pap smear. Providers may use the Pap smear as a marker of whether a woman has received screening for several other medical problems. Thus, the Pap smear can be considered a ''sentinel'' test for health screening in women, and efforts to identify women at high risk and increase health promotion and disease prevention in this group should focus on women who have not received this test.